Insecticide-Treated mosquito Bed Nets Linked to Reduction in Burkitt Lymphoma Incidence: JAMA

Written By :  Dr Riya Dave
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-04-21 17:15 GMT   |   Update On 2024-04-22 05:50 GMT

Researchers have found that the large-scale rollout of insecticide-treated bed nets (ITNs) in sub-Saharan Africa during the 2000s is associated with a significant reduction in the incidence of Burkitt lymphoma (BL) among children. According to a systematic review and meta-analysis published in JAMA Network Open by Nora S. this important finding highlights an additional benefit of malaria...

Login or Register to read the full article

Researchers have found that the large-scale rollout of insecticide-treated bed nets (ITNs) in sub-Saharan Africa during the 2000s is associated with a significant reduction in the incidence of Burkitt lymphoma (BL) among children. According to a systematic review and meta-analysis published in JAMA Network Open by Nora S. this important finding highlights an additional benefit of malaria control programs in the region.

Burkitt lymphoma (BL) is one of the most common childhood cancers in sub-Saharan Africa and has been etiologically linked to malaria. However, limited evidence has been available to demonstrate the impact of malaria interventions on BL incidence. The systematic review and meta-analysis aimed to investigate the potential association between the large-scale rollout of ITNs in sub-Saharan Africa and the incidence of BL in children aged 0 to 15 years.

The study involved a systematic review of epidemiological studies on BL incidence rates in children and adolescents in sub-Saharan African countries where malaria is endemic. Researchers searched the Embase, Global Health, and Medline databases, as well as cancer registry publications, to identify studies published between January 1, 1990, and February 27, 2023. The review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline.

Data were extracted independently by two reviewers, and the quality of studies was assessed based on predefined criteria: data collection, case ascertainment, and calculation of person-time at risk. The main outcomes and measures included the incidence rates of BL during childhood and mean ITN use in the population. Data were analyzed using a random-effects negative binomial regression model.

The key findings of the study were:

• Of the 2,333 studies meeting selection criteria, 23 studies comprising 66 data points on BL incidence were included in the analysis.

• The studies were based on 5,226 BL cases from locations with large-scale ITN use across 17 countries.

• The incidence rates of BL were found to be 44% (95% CI, 12%-64%) lower in the period after ITN introduction compared to before.

• The adjusted pooled incidence rates of BL were 1.36 (95% CI, 0.88-2.10) and 0.76 (95% CI, 0.50-1.16) per 100,000 person-years before and after ITN introduction, respectively.

• After adjusting for potential confounders, a 1-percentage point increase in mean ITN use in the population in the 10 years prior to BL data collection was associated with a 2% (95% CI, 1%-4%) reduction in BL incidence.

The systematic review and meta-analysis provide evidence that the large-scale rollout of ITNs in the 2000s is associated with a reduction in BL burden among children in sub-Saharan Africa. This study underscores the importance of malaria control programs and their potential to impact broader health outcomes in the region.

Reference:

Schmit, N., Kaur, J., & Aglago, E. K. (2024). Mosquito bed net use and burkitt lymphoma incidence in sub-Saharan Africa: A systematic review and meta-analysis. JAMA Network Open, 7(4), e247351. https://doi.org/10.1001/jamanetworkopen.2024.7351

Tags:    
Article Source : JAMA Network Open

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News